130 related articles for article (PubMed ID: 37079980)
1. Impact of venous thromboembolism on incidence of arterial thromboembolism - An analysis of German outpatient claims data.
Keller K; Kohring C; Farmakis IT; Valerio L; Barco S; Bätzing J; Akmatov MK; Konstantinides S; Münzel T; Hobohm L; Holstiege J
Thromb Res; 2023 Jun; 226():9-17. PubMed ID: 37079980
[TBL] [Abstract][Full Text] [Related]
2. Bevacizumab Use and the Risk of Arterial and Venous Thromboembolism in Patients with High-Grade Gliomas: A Nested Case-Control Study.
Lee I; Adimadhyam S; Nutescu EA; Zhou J; Asfaw AA; Sweiss KI; Patel PR; Calip GS
Pharmacotherapy; 2019 Sep; 39(9):921-928. PubMed ID: 31332810
[TBL] [Abstract][Full Text] [Related]
3. High Incidence of Arterial and Venous Thrombosis in Antineutrophil Cytoplasmic Antibody-associated Vasculitis.
Kang A; Antonelou M; Wong NL; Tanna A; Arulkumaran N; Tam FWK; Pusey CD
J Rheumatol; 2019 Mar; 46(3):285-293. PubMed ID: 30385704
[TBL] [Abstract][Full Text] [Related]
4. Risk factors of arterial thrombotic events after unprovoked venous thromboembolism, and after cancer associated venous thromboembolism: A prospective cohort study.
Noumegni SR; Didier R; Mansourati V; Tromeur C; Le Moigne E; Hoffmann C; Nasr B; Gentric JC; Guegan M; Poulhazan E; Lacut K; Bressollette L; Le Mao R; Couturaud F
Thromb Res; 2022 Jun; 214():93-105. PubMed ID: 35525202
[TBL] [Abstract][Full Text] [Related]
5. Incidence and Risk Factors of Pulmonary Hypertension After Venous Thromboembolism: An Analysis of a Large Health Care Database.
Lutsey PL; Evensen LH; Thenappan T; Prins KW; Walker RF; Farley JF; MacLehose RF; Alonso A; Zakai NA
J Am Heart Assoc; 2022 Jul; 11(14):e024358. PubMed ID: 35861839
[TBL] [Abstract][Full Text] [Related]
6. Symptomatic Venous Thromboembolism After Achilles Tendon Rupture: A Nationwide Danish Cohort Study of 28,546 Patients With Achilles Tendon Rupture.
Pedersen MH; Wahlsten LR; Grønborg H; Gislason GH; Petersen MM; Bonde AN
Am J Sports Med; 2019 Nov; 47(13):3229-3237. PubMed ID: 31574237
[TBL] [Abstract][Full Text] [Related]
7. Incidence of venous and arterial thromboembolic events reported in the tofacitinib rheumatoid arthritis, psoriasis and psoriatic arthritis development programmes and from real-world data.
Mease P; Charles-Schoeman C; Cohen S; Fallon L; Woolcott J; Yun H; Kremer J; Greenberg J; Malley W; Onofrei A; Kanik KS; Graham D; Wang C; Connell C; Valdez H; Hauben M; Hung E; Madsen A; Jones TV; Curtis JR
Ann Rheum Dis; 2020 Nov; 79(11):1400-1413. PubMed ID: 32759265
[TBL] [Abstract][Full Text] [Related]
8. Increased risk of venous and arterial thromboembolism in patients with colorectal cancer receiving cetuximab-based combination chemotherapy: A population-based study in Korea.
Yhim HY; Lee J; Kim KH; Kim SA; Lee JY; Hwang HG; Hong J; Lee JO; Bang SM
Thromb Res; 2023 Nov; 231():50-57. PubMed ID: 37804738
[TBL] [Abstract][Full Text] [Related]
9. Association between migraine and risk of venous thromboembolism: A nationwide cohort study.
Peng KP; Chen YT; Fuh JL; Tang CH; Wang SJ
Headache; 2016 Sep; 56(8):1290-9. PubMed ID: 27411732
[TBL] [Abstract][Full Text] [Related]
10. Impact of sex and traditional cardiovascular risk factors on the risk of recurrent venous thromboembolism: results from the German MAISTHRO Registry.
Linnemann B; Zgouras D; Schindewolf M; Schwonberg J; Jarosch-Preusche M; Lindhoff-Last E
Blood Coagul Fibrinolysis; 2008 Mar; 19(2):159-65. PubMed ID: 18277138
[TBL] [Abstract][Full Text] [Related]
11. [Estimating the incidence of venous thromboembolism (VTE) using various types of routine data of the German healthcare system].
Ohlmeier C; Leverkus F; Kloss S; Basic E; Bleß HH
Z Evid Fortbild Qual Gesundhwes; 2018 Dec; 139():46-52. PubMed ID: 30477975
[TBL] [Abstract][Full Text] [Related]
12. Relative risk of arterial and venous thromboembolism in persons with cancer vs. persons without cancer-a nationwide analysis.
Grilz E; Posch F; Nopp S; Königsbrügge O; Lang IM; Klimek P; Thurner S; Pabinger I; Ay C
Eur Heart J; 2021 Jun; 42(23):2299-2307. PubMed ID: 33769475
[TBL] [Abstract][Full Text] [Related]
13. JAK inhibitors and risk of major cardiovascular events or venous thromboembolism: a self-controlled case series study.
Gouverneur A; Avouac J; Prati C; Cracowski JL; Schaeverbeke T; Pariente A; Truchetet ME
Eur J Clin Pharmacol; 2022 Dec; 78(12):1981-1990. PubMed ID: 36284012
[TBL] [Abstract][Full Text] [Related]
14. Incidence and impact of venous thromboembolism in hospitalized patients with Crohn's disease.
Keller K; Sivanathan V; Schmitt VH; Ostad MA; Münzel T; Espinola-Klein C; Hobohm L
Thromb Res; 2022 Nov; 219():77-85. PubMed ID: 36137330
[TBL] [Abstract][Full Text] [Related]
15. Prospective controlled cohort study on the safety of a monophasic oral contraceptive containing nomegestrol acetate (2.5mg) and 17β-oestradiol (1.5mg) (PRO-E2 study): risk of venous and arterial thromboembolism.
Reed S; Koro C; DiBello J; Becker K; Bauerfeind A; Franke C; Heinemann K
Eur J Contracept Reprod Health Care; 2021 Dec; 26(6):439-446. PubMed ID: 34644228
[TBL] [Abstract][Full Text] [Related]
16. Risk of recurrent venous thromboembolism in patients with HIV infection: A nationwide cohort study.
Rokx C; Borjas Howard JF; Smit C; Wit FW; Pieterman ED; Reiss P; Cannegieter SC; Lijfering WM; Meijer K; Bierman W; Tichelaar V; Rijnders BJA;
PLoS Med; 2020 May; 17(5):e1003101. PubMed ID: 32407386
[TBL] [Abstract][Full Text] [Related]
17. A nationwide family study of venous thromboembolism and risk of arterial vascular disease.
Zöller B; Li X; Sundquist J; Sundquist K
Heart; 2016 Aug; 102(16):1315-21. PubMed ID: 27048773
[TBL] [Abstract][Full Text] [Related]
18. Incidence of major adverse cardiovascular events among patients with provoked and unprovoked venous thromboembolism: Findings from the Registro Informatizado de Enfermedad Tromboembólica Registry.
Golemi I; Cote L; Iftikhar O; Brenner B; Tafur A; Bikdeli B; Fernández-Capitán C; Pedrajas JM; Otero R; Quintavalla R; Monreal M;
J Vasc Surg Venous Lymphat Disord; 2020 May; 8(3):353-359.e1. PubMed ID: 31784355
[TBL] [Abstract][Full Text] [Related]
19. Incidence, risk factors, and outcomes of venous and arterial thromboembolism in immune checkpoint inhibitor therapy.
Moik F; Chan WE; Wiedemann S; Hoeller C; Tuchmann F; Aretin MB; Fuereder T; Zöchbauer-Müller S; Preusser M; Pabinger I; Ay C
Blood; 2021 Mar; 137(12):1669-1678. PubMed ID: 33067632
[TBL] [Abstract][Full Text] [Related]
20. Impact of risk factors on the occurrence of arterial thrombosis and venous thromboembolism in adults with primary immune thrombocytopenia - Results from two nationwide cohorts.
Ekstrand C; Linder M; Baricault B; Lafaurie M; Sailler L; Lapeyre-Mestre M; Kieler H; Moulis G; Bahmanyar S
Thromb Res; 2019 Jun; 178():124-131. PubMed ID: 31026663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
